Oncolytics Biotech® Inc. (NASDAQ:ONCY) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of cancer of the fallopian tube. On Monday shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) closed at $1.07.
On February 25, it was reported that, SunEdison Inc. (NYSE:SUNE) through its global wing SunEdison Social Innovations will commence an initiative to provide electricity for 20 million by 2020 all over the world. “We are committing to bringing electricity to one million people by the end of 2015, and are targeting to help 20 million people gain access to electricity by 2020,” said Ahmad Chatila, president, CEO, SunEdison. SunEdison, Inc. (NYSE:SUNE) in last trading activity moved up 2.80% to close at $22.76. Company weekly performance is 1.34% while its quarterly performance stands at 0.22%. SunEdison, Inc. (NYSE:SUNE) is -6.53% away from its 52 week high.
ClearOne, Inc. (NASDAQ:CLRO) announced it will release its financial results for the fourth quarter and full year ended December 31, 2014 before the market opens on Thursday, March 12, 2015. On last trading day ClearOne, Inc. (NASDAQ:CLRO) decreased -0.78% to close at $10.23. Its volatility for the week is 1.17% while volatility for the month is 3.02%. CLRO’s sales growth for past 5 years was 6.80% and its EPS growth for past 5 years was 18.00%. ClearOne, Inc. (NASDAQ:CLRO) monthly performance is -2.20%.
On February 26, Exterran Holdings Inc. (NYSE:EXH) reported fourth-quarter earnings of $19.1 million. For the year, the company reported profit of $98.2 million, or $1.40 per share. Revenue was reported as $2.9 billion. Exterran Holdings, Inc. (NYSE:EXH) has 0.30% insider ownership while its institutional ownership stands at 96.40%. In last trading activity company’s stock closed at $32.27.
Proofpoint, Inc (NASDAQ:PFPT) has entered into a definitive agreement to acquire Emerging Threats, a leading provider of advanced threat intelligence, for approximately $40 million in cash and stock. Proofpoint will integrate Emerging Threats’ advanced threat intelligence with its existing Targeted Attack Protection and Threat Response security solutions to deliver another significant step forward in advancing the state of the art for advanced threat detection and response, across the complete attack chain. On last trading day Proofpoint, Inc. (NASDAQ:PFPT) moved up 0.76% to close at $57.07. Its volatility for the week is 2.72% while volatility for the month is 3.35%. PFPT’s sales growth for past 5 years was 32.20% and its EPS growth for past 5 years was -20.80%. Proofpoint, Inc. (NASDAQ:PFPT) monthly performance is 13.87%.